Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of SHR8008 vs. Fluconazole in Subjects With Acute Vulvovaginal Candidiasis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing SHR8008 to fluconazole for acute vulvovaginal candidiasis is underway.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvovaginal Candidiasis

Drugs mentioned

• SHR8008

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Acute Vulvovaginal Candidiasis | Phase 3 | Status: UNKNOWN